Permanent gene correction by means of nucleotide-modified messenger rna
AssigneesEberhard Karls Universität Tübingen Medizinische Fakultät, Helmholtz-Zentrum für Infektionsforschung GmbH für das Helmholtz-Institut für Pharmazeutische
InventorsMichael KORMANN, Lauren Mays WEDDLE, Claus-Michael LEHR, Brigitta LORETZ, Emad MALAEKSEFAT
Life of this patent
Estimating the term…
Abstract
The present invention relates to a nucleotide-modified messenger RNA for the permanent correction of a genetic alteration on a DNA. The invention further relates to a nucleotide-modified messenger RNA in combination with a repair template. It also relates to a pharmaceutical composition. It finally relates to methods for the correction of a genetic alteration on a DNA.
Claims35
A nuclease-encoding nucleotide-modified messenger RNA (nec-mRNA) configured for preconditioning the correction of a genetic alteration on a DNA, wherein in the nec-mRNA up to including approx. 50% of the uridine nucleotides and up to including approx. 50% of the cytidine nucleotides are modified by exchanging uridine for 2-thiouridine (s2U) or pseudouridine (ψ), and by exchanging cytidine for 5-methylcytidine (m5C).
(canceled)
17-18. (canceled)
Dependencies are inferred from the claim text.